Elsevier,

iPSCs - State of the Science
Volume 16 in Advances in Stem Cell Biology
2022, Pages 197-224

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by focusing on the uses of iPSCs in inherited diseases and, particularly, in the case of Gaucher disease (GD).
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by highlighting the types of human podiatry disabilities and correction methods using traditional, 3DP technology and its challenges.
Elsevier,

Progress in Brain Research
Volume 268, Issue 1, 2022, Pages 191-215

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information about pituitary adenomas and the complex collection of disorders they produce.
Elsevier,

Pickwell's Binocular Vision Anomalies (Sixth Edition)
2022, Pages 91-95

This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by providing diagnostic occlusion and investigative occlusion for better patient outcomes..
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by showing how the issue of “inclusion” could be affected by the advancement of artificial intelligence (AI) in medicine through the interaction between rare diseases (RDs) and AI technology.
Elsevier,

Critical Care Rare Disease, Volume 17, Issue 1, January 2022, Pages 13-29

This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing insights into diagnostic access for undiagnosed and rare diseases in critical care
This content links with Goal 3: Good health and well-being and Goal 10: Reduced Inequalities by providing information on the diagnosis and management of cardiovascular involvement in Fabry Disease.
This content aligns with Goal 3: Good Health as well as Goal 10: Reduced Inequalities by bringing to light research on HPV and breast cancer in women.
This chapter advances Goals 7, 16, and 10 by applying an energy justice framework and some concepts from political ecology to identify the distribution of injustices in the lithium global production network. The authors argue that power asymmetries are significant and that more inclusive decision-making processes are needed for the transition to electro-mobility to be compatible with sustainable development and social justice.
This book chapter advances SDG #3 and #10 by reviewing the latest developments in the field of clinical diagnosis and pharmacotherapeutics have provided hope to ameliorate the behavioral changes and cognitive disturbances associated with the disease.

Pages